Silica
- Manufacturer
- Uriel Pharmacy Inc
- Effective date
- 2017-07-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:08:52
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Purpose
Uses: To promote skin elasticity and strengthen hair and nails.
Dosage & Administration
Directions: Take regularly before meals with a small amount of water. Ages 12 and older: 1 tsp. Ages 2-11: 1/2 tsp. Under age 2: Ask a doctor.
OTC-Active Ingredient
Active Ingredients: Stannum met. (Metallic tin) 3X, Cinis equiseti (Ash of horsetail herb) 5X, Cinis quercus (Decoction of oak bark ash) 9X, Cor (Bovine heart) 9X, Hepar (Bovine liver) 9X, Pancreas (Bovine pancreas) 9X, Pulmo (Bovine lung) 9X, Quercus (Oak) 9X, Renes (Bovine kidneys) 9X, Mesenchyme (Porcine embryonic connective tissue) 11X
Inactive Ingredient
Inactive Ingredients: Lactose, Bee pollen, Diatomaceous earth, Anise oil, Mesenchyme, Pancreas, Pulmo, Cor, Renes.
Keep out of reach of children
KEEP OUT OF REACH OF CHILDREN.
Do not use if allergic to any ingredient. Do not use if safety seal is broken or missing.
Warnings:
Do not use if allergic to any ingredient. Do not use if safety seal is broken or missing.
Ask doctor section
Consult your doctor if you are lactose intolerant.
Pregnancy or breast feeding section
If you are pregnant or nursing, consult a doctor before use.
Questions section
Made with care by
Uriel Pharmacy
East Troy, WI 53120
Questions or comments?
Please call 1.866.642.2858
www.urielpharmacy.com
Principal Display Panel
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 48951-8317-7 | Silica | 1 in 1 BOTTLE, GLASS | POWDER | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 48951-8317 | SILICA POWDER [URIEL PHARMACY INC] | 2 | Legacy NDC, 1 package rows | 20170724_32840bc0-2dfb-11df-8a39-0800200c9a66.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| EQUISETUM ARVENSE TOP | ACTIVE INGREDIENT | 1DP6Y6B65Z | 1 | |
| MAMMAL LIVER | ACTIVE INGREDIENT | D0846624BI | 1 | |
| WHITE OAK BARK | ACTIVE INGREDIENT | 93LP7Y8EGT | 1 | |
| EQUISETUM ARVENSE TOP | ACTIVE MOIETY | 1DP6Y6B65Z | 1 | |
| MAMMAL LIVER | ACTIVE MOIETY | D0846624BI | 1 | |
| WHITE OAK BARK | ACTIVE MOIETY | 93LP7Y8EGT | 1 | |
| ANISE OIL | INACTIVE INGREDIENT | 6Y89129C8H | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| POLLEN | INACTIVE INGREDIENT | 3729L8MA2C | 1 |
Products#
Every source-derived product name is available through these pages.
- Silica
- LACTOSE
- POLLEN
- ANISE OIL
- EQUISETUM ARVENSE TOP
- WHITE OAK BARK
- MAMMAL LIVER
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 48951-8317 | 48951-8317-7 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE | J2B2A4N98G | IACT |
| POLLEN | 3729L8MA2C | IACT |
| ANISE OIL | 6Y89129C8H | IACT |
| EQUISETUM ARVENSE TOP | 1DP6Y6B65Z | ACTIB |
| WHITE OAK BARK | 93LP7Y8EGT | ACTIB |
| MAMMAL LIVER | D0846624BI | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / RECTAL | 8 %w/v | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | PASTE, DENTIFRICE / DENTAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | POWDER, DENTIFRICE / DENTAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | ELIXIR / ORAL | 0.15 ml/5ml | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | SOLUTION / ORAL | 1.4 mg | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | DROPS / ORAL | 0.4 mg/1ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | SUSPENSION / ORAL | 1 ml/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | PASTILLE / ORAL | 16 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 551153e9-cc50-5cb8-e054-00144ff88e88 | 32840bc0-2dfb-11df-8a39-0800200c9a66 | 2017-07-24 | Warnings | 551153e9-cc50-5cb8-e054-00144ff88e88 32840bc0-2dfb-11df-8a39-0800200c9a66 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
